Opioids in Medicare Part D: Concerns About Extreme Use and Questionable Prescribing. | AHRQ Patient Safety Network

Opioids in Medicare Part D: Concerns About Extreme Use and Questionable Prescribing. | AHRQ Patient Safety Network

• Book/Report
 
• Published July 2017

Opioids in Medicare Part D: Concerns About Extreme Use and Questionable Prescribing.

Office of the Inspector General. Washington, DC: US Department of Health and Human Services; July 2017. Report No. OEI-02-17-00250.

Misuse of prescription opioids represents a serious patient safety issue. This data brief reviews federal Medicare statistics on opioid use by older Americans to highlight patient behaviors and provider prescribing patterns that could indicate, contribute to, or perpetuate unsafe opioid use.

InformationFree full text (PDF)Related report (PDF)Related news article

Related Resources

JOURNAL ARTICLE › REVIEW

Prescription opioid analgesics commonly unused after surgery: a systematic review.

Bicket MC, Long JJ, Pronovost PJ, Alexander CG, Wu CL. JAMA Surg. 2017 Aug 2; [Epub ahead of print].

JOURNAL ARTICLE › STUDY

Improving adherence to long-term opioid therapy guidelines to reduce opioid misuse in primary care: a cluster-randomized trial.

Liebschutz JM, Xuan Z, Shanahan CW, et al. JAMA Intern Med. 2017 Jul 17; [Epub ahead of print].

JOURNAL ARTICLE › REVIEW

Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: a systematic review.

Frank JW, Lovejoy TI, Becker WC, et al. Ann Intern Med. 2017 Jul 18; [Epub ahead of print].

BOOK/REPORT

Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use.

Bonnie RJ, Ford MA, Pillips JK, eds. Washington, DC: National Academies Press; 2017.

JOURNAL ARTICLE › STUDY

Vital signs: changes in opioid prescribing in the United States, 2006–2015.

Guy GP Jr, Zhang K, Bohm MK, et al. MMWR Morb Mortal Wkly Rep. 2017;66:697-704.

View More